Evidence map›Paper›PMID 32395624›Full record

ArticleBiology methods & protocols2019

Plasma or serum? A qualitative study on rodents and humans using high-throughput microRNA sequencing for circulating biomarkers.

Thibault Dufourd, Noémie Robil, David Mallet, Carole Carcenac, Sabrina Boulet, Sonia Brishoual, Emilie Rabois, Jean-Luc Houeto, Pierre de la Grange, Sebastien Carnicella

Open access · goldAbstract read
In one paragraph

Article in Biology methods & protocols, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Thibault DufourdInserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France.
Noémie RobilGenosplice, Paris, France.
David MalletInserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France.
Carole CarcenacInserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France.
Sabrina BouletInserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France.
Sonia BrishoualCIC/CRB INSERM 1402, CHU de Poitiers, France.
Emilie RaboisCIC/CRB INSERM 1402, CHU de Poitiers, France.
Jean-Luc HouetoCIC/CRB INSERM 1402, CHU de Poitiers, France.
Pierre de la GrangeGenosplice, Paris, France.
Sebastien CarnicellaInserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France.
Inserm · FRGrenoble Institute of Neurosciences · FRUniversité Grenoble Alpes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

microRNAs are small non-coding RNAs gaining interest for their potential roles as reliable biomarkers for the diagnosis and therapeutics of numerous pathologies, ranging from cancer to neurodegenerative or psychiatric disorders. Indeed, microRNAs are present in various accessible biofluids, including peripheral blood, and specific dysregulation of their expression may be associated with these different pathological conditions. microRNAs can be isolated from plasma or serum for sequencing with commercial kits. However, these two biofluids might exhibit some differences in their microRNA contents, due notably to the coagulation process occurring during serum collection. It remains unclear from previous studies and commercial recommendations which blood fraction is preferable. Because of the small amount of circulating microRNAs in a given blood volume, this question appears crucial for qualitative and quantitative optimization of microRNA profiling, especially in animal models used for investigating the pathophysiological relevancy of this approach. We therefore evaluated the efficiency of RNA isolation and microRNA levels from plasma and sera isolated from rats and humans, with a widely used extraction kit (QIAGEN miRNeasy), and assessed microRNA quality and quantity with high-throughput sequencing. Fewer reads with length corresponding to non-miRNAs sequences were observed in plasma than in serum, both from rats and humans. Moreover, rat plasma produced twice as many aligned reads compared to sera, as well as more aligned reads corresponding to microRNAs (84.6% against 38.7%), differences that were not find in human samples. Our results, therefore, clearly indicate that plasma should be preferred for miRNA investigations, particularly for translational studies.

Indexed as

biomarkerhigh-throughput sequencingmicroRNAplasmaserum

Identifiers

PMID32395624
PMCPMC7200924
OpenAlexW2950212163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.